Attivo Industries

Revision as of 15:55, 5 April 2022 by Aciria (talk | contribs) (Created page with "{{Infobox company | name = Attivo Industries | logo = File:Attivo.png | image = | image_size = | image_upright = <!-- default = 1 --> | image_alt = | image_caption = | typ...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Attivo Industries is an Acirian developer and researcher of biotechnology, microelectromechanical systems, robotics and related technologies. It was founded in 1976 by Imperial University graduates Fiorgenzo- and Doranzina Battantino with the capital investments of Valeano Sorretti. The Battentinos named the company after the Aciriano word meaning active and alive. The company specializes in prosthetics for civilian use, robotics for military- and industrial use and the research and development of exoskeletons for both civilian and military uses. Attivo Industries is known for their philanthropy, offering victims of accidents prosthetics free of charge.

Attivo Industries
Public
IndustryBiotechnology, Robotics, Automation
Founded1976
Founders
  • Fiorgenzo Battantino
  • Doranzina Battantino
  • Valeano Sorretti
Headquarters,
Area served
Worldwide
Key people
Doranzina Battantino (CEO) Fiorgenzo Battantino (CSO)
ProductsMicroelectromechanical systems, Medical microsystems, Powered exoskeletons
DivisionsBiomedical engineering, Robotics

The company also gained notoriety following the 2008 deal with the Acirian armed forces where they received a major grant for the development of exoskeletons and robotics for military use.

History

The Tai Yong Medical corporation was founded in Shanghai in 1977. It began as a designer and manufacturer of silicon-based prosthetic limbs. During the 1980s, TYM acquired two factories in China and established a network of clients in Southeast Asia. In 2009, the company became famous worldwide thanks to the work of its young leader Zhao Yun Ru. She started a collaboration with the military of China by providing prostheses to veteran amputees. In 2017, the corporation was invited to participate in the ambitious Hengsha Island project, which would later become the location of the company's headquarters.[5]

Attivo Industries was founded in Trossera in 1976. Originally, the company just designed and manufactured various prosthetic limbs, and experimented with different materials. During the 1980s the company bought out two factories and established a customer base in the rural areas of the country, where prosthetics were most needed due to various accidents. In 2008, the company gained nationwide attention for its deal with the Acirian armed forces where they provided prostheses for veteran amputees. This deal was expanded on further in 2012, when Attivo received a major grant for the development of exoskeletons and robotics for military use. Much of this research has been done in close cooperation with military officials, so little is known by the public of the developments made during this deal.

For the 2020s, Attivo Industries has announced their goal to be further expansion in foreign markets, the development of a lightweight energy source for their powered exoskeletons and highly advanced arm prosthetics.

Controversies

Attivo Industries is known for its aggressive expansion since the early 2000s, with competitors often being absorbed into the company. Attivo has been accused of corporate espionage by multiple companies both prior- and after their absorption into the company, most recent of these claims was the claim of Fastech Corporation, which claimed that Attivo Industries had stolen their exoskeleton design. Attivo has even been accused of staging controversies to lower the value of a company for a cheaper buyout, such as in the case of Mano Amico S.b.A, where their CEO was in the midst of an embezzlement controversy prior to the buyout, and Vita Migliore Inc, which had a catastrophic laboratory accident just weeks prior to the buyout.

Attivo Industries is also controversial for their voluntary human testing, with some of the patients suffering from crippling side effects following these tests. The patients are also required to sign a non-disclosure agreement. Despite these allegations, company CEO Doranzina Battantino insists that Attivo Industries prides themselves in maintaining a safe enviroment with an ethical approach to research.